Consensus document of the Spanish Society of Arteriosclerosis (SEA) for the prevention and treatment of cardiovascular disease in type 2 diabetes mellitus

Simple item page
dc.contributor.authorRuiz García, Antonio
dc.contributor.authorArranz Martínez, Ezequiel
dc.contributor.authorMorón Merchante, Ignacio
dc.contributor.authorPascual Fuster, Vicente
dc.contributor.authorTamarit, Juan J.
dc.contributor.authorTrias Villagut, Ferrán
dc.contributor.authorPinto Sala, Xavier
dc.contributor.authorAscaso, Juan F.
dc.contributor.authorGrupo de Diabetes de la Sociedad Española de Arteriosclerosis
dc.date.accessioned2021-06-15T14:24:07Z
dc.date.available2021-06-15T14:24:07Z
dc.date.issued2018
dc.description.abstractA consensus document of the Diabetes working group of the Spanish Society of Arteriosclerosis (SEA) is presented, based on the latest studies and conceptual changes that have appeared. It presents the cardiovascular risk in type 2 diabetes mellitus (T2DM) and the action guidelines for the prevention and treatment of cardiovascular disease (CVD) associated with T2DM. The importance of lipid control, based on the objective of LDL-C and non-HDL-C when there is hypertriglyceridemia, and the blood pressure control in the prevention and treatment of CVD is evaluated. The new hypoglycemic drugs and their effects on CVD are reviewed, as well as the treatment and control guidelines of hyperglycemia. Likewise, the use of antiplatelet agents is considered. Emphasis is placed on the importance of global and simultaneous action on all risk factors to achieve a significant reduction in cardiovascular events.spa
dc.description.filiationUEMspa
dc.description.impactNo data JCR 2018spa
dc.description.impact0.241 SJR (2018) Q3, 247/369 Cardiology and Cardiovascular Medicinespa
dc.description.impactNo data IDR 2018spa
dc.description.sponsorshipEsteve Pharmaceuticals, S.A.spa
dc.identifier.citationRuiz-García, A., Arranz-Martínez, E., Morón-Merchante, I., Pascual-Fuster, V., Tamarit, J. J., Trias-Villagut, F., Pintó-Sala, X., Ascaso, J. F., & Grupo de Diabetes de la Sociedad Española de Arteriosclerosis. (2018). Consensus document of the Spanish Society of Arteriosclerosis (SEA) for the prevention and treatment of cardiovascular disease in type 2 diabetes mellitus. Clínica e Investigación en Arteriosclerosis, 30(S1), 1–19. https://doi.org/10.1016/j.arteri.2018.06.006spa
dc.identifier.doi10.1016/j.arteri.2018.06.006
dc.identifier.issn0214-9168
dc.identifier.issn1578-1879
dc.identifier.urihttp://hdl.handle.net/11268/10148
dc.language.isoengspa
dc.peerreviewedSispa
dc.rights.accessRightsrestricted accessspa
dc.subject.otherDiabetes mellitus tipo 2spa
dc.subject.otherInhibidores de agregación plaquetariaspa
dc.subject.unescoEnfermedad cardiovascularspa
dc.subject.unescoTratamiento médicospa
dc.subject.unescoFarmacologíaspa
dc.titleConsensus document of the Spanish Society of Arteriosclerosis (SEA) for the prevention and treatment of cardiovascular disease in type 2 diabetes mellitusspa
dc.title.alternativeDocumento de consenso de la Sociedad Española de Arteriosclerosis (SEA) para la prevención y tratamiento de la enfermedad cardiovascular en la diabetes mellitus tipo 2spa
dc.typejournal articlespa
dspace.entity.typePublication

Files

Collections

Otras Áreas de Investigación de Salud